Joining the worried crowd is Morgan Stanley Wealth Management's chief investment officer Lisa Shalett, who warns of "cracks" in the boom story around AI capital expenditure.

The first reported demonstration of “unconditional” quantum advantage has little practical value—but that's perhaps why it matters.

Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its ...